الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 123 |  |  |
| | | from | 123 | | |
Abstract
COVID-19 most commonly presents with respiratory
symptoms, including cough, shortness of breath, sore throat
with characteristics of loss of smell and taste. However,
digestive symptoms also occur in patients with COVID-19
and are often described in outpatients with less severe
disease.
This study aims to estimate the rate of GI symptoms,
liver enzyme levels outside reference ranges, and fecal tests
for H. Pylori antigen among patients with the suspected
COVID-19.
The research performed on 70 Egyptian patients who
have suspected COVID-19 symptoms included in this
study. The patients are divided into four groups.
Asymptomatic group, group with respiratory symptoms,
group with digestive symptoms, and group with respiratory
and digestive symptoms.
In summary, this study concludes that fever is the
most common symptom in COVID-19. It was 61.4% while
Diarrhea is the most common gastrointestinal symptom of
COVID-19.
The asymptomatic patient was 10%, gastrointestinal
symptoms with or without respiratory symptoms 24.3%,
digestive symptoms only 11.8% of COVID-19, and H.
pylori present in 50% of the digestive group of COVID-19
patients.
The use of corticosteroids in the low effective dose
for ten days to 2 weeks and anticoagulant play an important
role in the management of COVID-19, especially in
moderate cases